ClinicalTrials.gg
RecruitingNCT07870356AGREE-BPUpdated Oct 22, 2026

Measurement Agreement Between IBP and NIBP During Induction of Anesthesia in High Risk Patients

An observational study in Blood Pressure Monitoring, sponsored by Medical University of Graz. Recruiting at 1 site in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Medical University of Graz · Observational

Updated Oct 22, 2026Now RecruitingSite recruiting status changed+2 moreGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
18 Years and older
Sex
All
01

Study summary

The AGREE-BP study aims to evaluate how closely blood pressure measurements taken with an automated upper-arm cuff agree with measurements taken through a small plastic tube placed in an artery, called an arterial catheter, during the start of general anesthesia.

Blood pressure can change rapidly when patients receive medication to induce general anesthesia. These changes may be particularly pronounced in patients with heart or blood vessel disease or high blood pressure. An upper-arm cuff measures blood pressure at intervals, whereas an arterial catheter measures it continuously with each heartbeat. Although cuff measurements are widely used, their agreement with arterial catheter measurements during this period of rapid change is not fully evaluated and validated.

This observational study will include 120 patients undergoing surgery under general anesthesia at University Hospital Graz, Austria. Participants will have conditions that increase their risk of blood pressure changes and will already require an arterial catheter before anesthesia for medical reasons.

During the first five minutes after administration of the medication used to induce anesthesia, researchers will record blood pressure using both methods. The cuff will be placed on the arm opposite the arterial catheter and will take measurements at least once per minute, or more frequently if the monitor allows. Anesthesia and treatment decisions will remain the responsibility of the treating clinician. Participation does not require additional follow-up visits.

The main aim is to assess agreement in mean arterial pressure, which is the average pressure in the arteries over a heartbeat. Researchers will also compare systolic pressure, the pressure when the heart contracts, and diastolic pressure, the pressure when the heart relaxes. They will examine whether patient characteristics or treatments are associated with differences between the two measurement methods and will separately assess agreement during particularly large, rapid blood pressure changes.

The findings may help clinicians understand when cuff measurements differ meaningfully from arterial catheter measurements and inform future decisions about blood pressure monitoring during the start of anesthesia.

02

Conditions studied

  • Blood Pressure Monitoring
03

In context

Lead sponsor

Medical University of Graz is the lead sponsor of 470 studies on the registry; 98 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults patients with a high-risk of hemodynamic changes during induction of anesthesia undergoing general anesthesia induction with clinically indicated intraarterial blood pressure monitoring before induction.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Intraarterial blood pressure monitoring prior to induction of anesthesia is necessary for clinical reasons
  2. Surgery under general anesthesia
  3. Provision of written informed consent
  4. Less than a 5 mmHg difference between consecutive non-invasive oscillometric blood pressure measurements on the left and right arms
  5. Supine positioning during induction of anesthesia possible and used for clinical reasons.
  6. At least one of the following factors indicating high-risk of blood pressure changes during induction of anesthesia:

    1. Peripheral arterial disease
    2. Carotid artery disease
    3. Severe coronary artery disease
    4. Arterial hypertension requiring three or more antihypertensive agents

Exclusion criteria

Exclusion Criteria:

  1. Inability to insert the intraarterial catheter and venous catheter on the same arm (mandatory to be on the contralateral side of the non-invasive oscillometric measurement)
  2. Pregnancy
  3. Planned awake fiberoptic intubation
  4. Previous enrollment in the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No

Interventions

  • Othernon-invasive oscillometric blood pressure monitoring

    In addition to intraarterial blood pressure monitoring, non-invasive oscillometric blood pressure monitoring will be performed on the contralateral arm.

    Also known as: NIBP

06

What researchers measure

Primary outcomes

  1. Mean arterial pressure measurement Agreement between IBP and NIBP

    Measurement agreement in mean arterial pressure between intraarterial (reference test) and intermittent non-invasive oscillometric (index test) blood pressure monitoring in high-risk patients having induction of anesthesia.

    Time frame: In the first five minutes after induction of anesthesia.

Secondary outcomes

  1. Diastolic arterial pressure measurement agreement between IBP and NIBP

    Measurement agreement of diastolic arterial pressure between intraarterial (reference test) and intermittent non-invasive oscillometric (index test) blood pressure monitoring in high-risk patients having induction of anesthesia.

    Time frame: In the first five minutes after induction of anesthesia.

  2. Systolic arterial pressure measurement Agreement between IBP and NIBP

    Measurement agreement of systolic arterial pressure between intraarterial (reference test) and intermittent non-invasive oscillometric (index test) blood pressure monitoring in high-risk patients having induction of anesthesia. Time Frame: In the first five minutes after induction of anesthesia

    Time frame: In the first five minutes after induction of anesthesia.

  3. Characteristics associated with disagreement between IBP and NIBP

    Patient and/or treatment characteristics associated with pairwise disagreement (\>10 mmHg) between intraarterial (clinical reference) and intermittent non-invasive oscillometric (index test) blood pressure monitoring in high-risk patients having induction of anesthesia.

    Time frame: In the first five minutes after induction of anesthesia.

Other outcomes

  1. Subgroup Analysis in patients with severe blood pressure changes

    In a predefined subgroup analysis, the primary aim and secondary aims 1 and 2 will be evaluated in situations with severe blood pressure changes (a change ≥ 50 mmHg within one minute).

    Time frame: In the first five minutes after induction of anesthesia.

07

Study locations

1 of 1 sites recruiting
  • Medical University of Graz, Department of Anaesthesiology and Intensive Care Medicine
    Graz, Styria 8010, Austria
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Anonymized data will be shared on reasonable request.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Timeline

3 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2026 (actual). Primary completion is estimated for Sep 2027, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2026
First posted
Oct 13, 2026
StartActual
Oct 7, 2026
Primary completionEst.
Sep 2027
CompletionEst.
Oct 2027
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 22, 2026
Sites
Medical University of Graz, Department of Anaesthesiology and Intensive Care Medicine is now Recruiting
Oct 22, 2026
Also revised
primary outcomes
Registered
First appeared on the registry
Oct 13, 2026
Show all 3 updates
  1. Oct 22, 2026
    Not yet recruiting→Recruiting
    Medical University of Graz, Department of Anaesthesiology and Intensive Care Medicine is now Recruiting
    + 1 other change: date precision
  2. Oct 16, 2026
    Primary outcomes Revised (2 changes)
    + 4 other changes: identifiers, description, conditions and secondary outcomes
  3. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07870356
Responsible party
Sponsor
First posted
Oct 13, 2026
Start date
Oct 7, 2026
Primary completion
Sep 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Oct 22, 2026

Study contacts

Michael Eichlseder, MD PhD
Contact
michael.eichlseder@medunigraz.at
+43 316 385 81919
Nikolaus Schreiber, MD PhD
Contact
nikolaus.schreiber@medunigraz.at
+43 316 385 81917
Michael Eichlseder, MD PhD
principal investigator · Medical University of Graz, Department of Anaesthesiology and Intensive Care Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion